GlassScriptPhysician profile
Christopher D Pankiw
NPI 1558667089
$10,921.90
in general payments reported to CMS, 2019-2025
29 companies · $975 in 2025
The $975 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,945 · 2020: $19.10 · 2021: $1,294 · 2022: $367 · 2023: $1,412 · 2024: $1,910 · 2025: $975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,861 · Travel and Lodging: $1,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,860.75 |
| Travel and Lodging | $1,436.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,826.00 | 2019 | |
| Smith+Nephew, INC. | $2,265.35 | 2019-2025 | Aetos Shoulder System, Twinfix, Real Intelligence |
| Trimed, INC. | $1,258.36 | 2019-2025 | |
| Alpha Orthopedic Systems | $612.14 | 2019 | |
| Fx Shoulder Solutions, INC | $568.76 | 2019-2025 | |
| Restor3d, INC. | $416.66 | 2023-2024 | |
| Zimvie INC. | $381.10 | 2023 | |
| Extremity Medical | $254.31 | 2023 | Io Fix |
| Linvatec Corporation | $194.57 | 2023-2024 | Biobrace 23mm, Linvatec Extremities |
| Stryker Corporation | $135.58 | 2021-2025 | Blueprint Patient Specific Instrumentation |
| Lima USA, INC. | $125.12 | 2019 | |
| Biopoly LLC | $106.00 | 2024 | |
| Medartis INC. | $96.07 | 2019-2025 | Aptus |
| Axogen | $88.95 | 2019-2023 | Avance Nerve Graft |
| Endo Pharmaceuticals INC. | $83.81 | 2019-2023 | Xiaflex |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrosurface Incorporated | $76.99 | 2019 | |
| Horizon Therapeutics Plc | $59.27 | 2019-2023 | Krystexxa |
| Polymedics Innovations INC. | $57.64 | 2023 | |
| Djo, LLC | $51.29 | 2023-2025 | Cmf |
| Globus Medical, INC. | $49.62 | 2022 | |
| Bioventus LLC | $40.63 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Kowa Pharmaceuticals America, INC. | $34.01 | 2022-2023 | Seglentis |
| Endo USA, INC. | $31.22 | 2024-2025 | Xiaflex |
| Astrazeneca Pharmaceuticals LP | $25.07 | 2025 | Wainua |
| Orthofix Medical, INC. | $23.13 | 2021-2023 | Physio-Stim |
| Pacira Therapeutics, INC. | $19.10 | 2020 | |
| Solventum Corporation | $14.56 | 2024 | Activ.A.C. |
| Vertex Pharmaceuticals Incorporated | $14.19 | 2025 | |
| Abbvie INC. | $12.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Pankiw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.